MedPath

Mitiglinide

Generic Name
Mitiglinide
Drug Type
Small Molecule
Chemical Formula
C19H25NO3
CAS Number
145375-43-5
Unique Ingredient Identifier
D86I0XLB13

Overview

Mitiglinide is a drug for the treatment of type 2 diabetes. It may stimulate insulin secretion in beta-cells by closing off ATP dependant potassium ion channels.

Indication

用于改善2型糖尿病患者餐后高血糖(仅限用于经饮食、运动疗法不能有效控制血糖的患者或在饮食、运动疗法的基础上加用α-葡萄糖苷酶抑制剂后仍不能有效控制血糖的患者)。

Associated Conditions

  • Blood Glucose, Postprandial
  • Type 2 Diabetes Mellitus

Clinical Trials

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Mitiglinide Calcium Capsules
国药准字H20153263
化学药品
胶囊剂
7/30/2020
Mitiglinide Calcium Tablets
国药准字H20120121
化学药品
片剂
8/25/2022
Mitiglinide Calcium Tablets
国药准字HJ20140874
化学药品
片剂
9/22/2023
Mitiglinide Calcium Tablets
国药准字HJ20140877
化学药品
片剂
9/22/2023
Mitiglinide Calcium Tablets
国药准字HJ20140875
化学药品
片剂
9/22/2023
Mitiglinide Calcium Tablets
国药准字HJ20140876
化学药品
片剂
9/22/2023
Mitiglinide Calcium Tablets
国药准字H20100125
化学药品
片剂
6/30/2020
Mitiglinide Calcium Tablets
国药准字H20120019
化学药品
片剂
6/13/2023
Mitiglinide Calcium Tablets
国药准字H20173166
化学药品
片剂
5/6/2022
Mitiglinide Calcium Tablets
国药准字H20173169
化学药品
片剂
5/12/2022

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.